ONCONETIX INC (ONCO) Stock Price & Overview
NASDAQ:ONCO • US68237Q2030
The current stock price of ONCO is 0.57 USD. Today ONCO is down by -15.52%. In the past month the price decreased by -57.78%. In the past year, price decreased by -97.08%.
ONCO Key Statistics
- Market Cap
- 889.2K
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -350.74
- Dividend Yield
- N/A
ONCO Stock Performance
ONCO Stock Chart
ONCO Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ONCO. When comparing the yearly performance of all stocks, ONCO is a bad performer in the overall market: 99.41% of all stocks are doing better.
ONCO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ONCO. ONCO may be in some trouble as it scores bad on both profitability and health.
ONCO Earnings
ONCO Forecast & Estimates
ONCO Groups
Sector & Classification
ONCO Financial Highlights
Over the last trailing twelve months ONCO reported a non-GAAP Earnings per Share(EPS) of -350.74. The EPS increased by 95.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -258.38% | ||
| ROE | -1506.13% | ||
| Debt/Equity | 0.05 |
ONCO Ownership
ONCO Latest News, Press Relases and Analysis
ONCO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16 | 417.437B | ||
| AMGN | AMGEN INC | 16.31 | 204.229B | ||
| GILD | GILEAD SCIENCES INC | 16.27 | 183.894B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.6 | 121.25B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.47 | 83.255B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 47.84 | 43.24B | ||
| INSM | INSMED INC | N/A | 31.965B | ||
| NTRA | NATERA INC | N/A | 28.775B | ||
| BIIB | BIOGEN INC | 12.36 | 27.876B | ||
| MRNA | MODERNA INC | N/A | 22.581B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.24 | 21.486B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 20.053B | ||
| EXAS | EXACT SCIENCES CORP | 308.82 | 19.749B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ONCO
Company Profile
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 5 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
Company Info
ONCONETIX INC
201 E. Fifth Street, Suite 1900
Cincinnati OHIO US
Employees: 5
Phone: 13024977115
ONCONETIX INC / ONCO FAQ
What does ONCONETIX INC do?
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 5 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
What is the stock price of ONCONETIX INC today?
The current stock price of ONCO is 0.57 USD. The price decreased by -15.52% in the last trading session.
Does ONCONETIX INC pay dividends?
ONCO does not pay a dividend.
What is the ChartMill rating of ONCONETIX INC stock?
ONCO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the market capitalization of ONCO stock?
ONCONETIX INC (ONCO) has a market capitalization of 889.20K USD. This makes ONCO a Nano Cap stock.
When does ONCONETIX INC (ONCO) report earnings?
ONCONETIX INC (ONCO) will report earnings on 2026-06-01, after the market close.